aminoglutethimide has been researched along with tamoxifen in 192 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 109 (56.77) | 18.7374 |
| 1990's | 55 (28.65) | 18.2507 |
| 2000's | 21 (10.94) | 29.6817 |
| 2010's | 7 (3.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Beyer, C; Larsson, K; Moralí, G; Naftolin, F | 1 |
| Pritchard, KI; Trudeau, ME | 1 |
| Bogart, MH; Lance, VA | 1 |
| Hisamatsu, K; Nomura, Y; Tashiro, H | 1 |
| Arnold, W; Fichtner, I; Görlich, M; Hauff, P; Staab, HJ; Winterfeld, G | 1 |
| Aakvaag, A; Johannessen, DC; Lien, EA; Lønning, PE | 1 |
| Abe, K | 1 |
| Anderson, ED; Anderson, TJ; Chetty, U; Forrest, AP; Hawkins, RA; Leonard, RC | 1 |
| Focan, C | 1 |
| Fukuoka, M; Kitawaki, J; Okada, H; Yamamoto, T | 1 |
| Namer, M | 2 |
| Farndon, JR; Henry, JA; Mallick, UK; May, FE; Nicholson, S; Piggott, NH; Westley, BR | 1 |
| Hussain, SP; Jannu, LN; Kumari, MV; Rao, AR | 1 |
| Garcia Giralt, E; Omodei Zorini, C | 1 |
| Biakhov, MIu; Meshcheriakova, NG; Vasiuta, NIu; Voznyĭ, EK | 1 |
| Ashley, SE; Coombes, RC; Ellin, CL; Hardy, JR; Judson, IR; Powles, TJ; Sinnett, HD | 1 |
| Distler, W; von Matthiessen, H | 1 |
| Büchner, T; Hiddemann, W; Koenigsmann, M; Wörmann, B; Zühlsdorf, M | 1 |
| Biran, S; Brufman, G | 3 |
| Anderson, TJ; Jack, WJ; Miller, WR | 1 |
| Bezwoda, WR; Meyer, K; Seymour, L | 1 |
| Anker, G; Lien, EA; Lønning, PE; Solheim, E; Ueland, PM | 1 |
| Berger, U; Coombes, RC; McClelland, RA; Miller, LS; Powles, TJ | 1 |
| Chambers, P; Farndon, JR; Halcrow, P; Harris, AL; Nicholson, S; Sainsbury, JR | 1 |
| Fekete, S; Gráf, F; Raposa, T; Várkonyi, J | 1 |
| Anderson, ED; Chetty, U; Forrest, AP; Hawkins, RA; Levack, PA | 1 |
| Fukutomi, T | 1 |
| Stein, RS | 1 |
| Gundersen, S; Klepp, R; Kvinnsland, S; Lund, E; Lundgren, S; Lønning, PE | 1 |
| Andersen, J; Poulsen, HS | 1 |
| Coolen, D; Hermans-Debaive, C; Mathijs, R | 1 |
| Fabre, JF; Martin, PM; Pourreau-Schneider, N; Puissant, A | 1 |
| Bella, M; Bisagni, G; Ceci, G; Cocconi, G; Passalacqua, R | 1 |
| Büchner, T; Hiddemann, W; Van de Loo, J; Volkenandt, M | 1 |
| Di Lauro, L; Lazzaro, B; Lopez, M; Papaldo, P | 1 |
| Samonigg, H | 1 |
| Enomoto, K; Fukutomi, T; Ikeda, T; Ishibiki, K; Isobe, Y; Kikuyama, S; Kubota, T; Nakamura, A; Nishiumi, T; Shimada, A | 1 |
| Carlström, K; Pousette, A; Rannevik, G; Sköldefors, H; Theve, NO; Wilking, N | 1 |
| Manni, A | 1 |
| Jonat, W; Maass, H | 1 |
| Bhatnagar, AS; Matter, A; Schieweck, K | 1 |
| Petru, E; Schmähl, D | 1 |
| Kvinnsland, S; Lönning, PE; Lundgren, S; Wiedemann, G | 1 |
| Canney, PA; Griffiths, T; Latief, TN; Mould, JJ; Priestman, TJ; Spooner, D | 1 |
| Alonso-Muñoz, MC; Beltran-Fabregat, M; Borrás-Balada, J; Cardenal-Alemany, F; Dorca-Ribugent, J; Fabregat-Mayol, J; Gómez-Batiste, X; López-López, L; Ojeda-González, MB; Viladiu-Quemada, P | 1 |
| Tominaga, T | 1 |
| Mouridsen, HT; Rose, C | 1 |
| Dogliotti, L; Maschietto, M; Ortega, C | 1 |
| Brodie, AM; Santen, RJ | 1 |
| Angus, B; Chambers, P; Farndon, JR; Halcrow, P; Harris, AL; Nicholson, S; Sainsbury, JR | 1 |
| Miller, WR | 1 |
| Büchner, T; Göhde, W; Hiddemann, W; Wörmann, B | 1 |
| Harvey, HA; Lipton, A; Santen, RJ | 2 |
| Ahmann, DL; Chang, MN; Creagan, ET; Edmonson, JH; Green, SJ; Ingle, JN; Long, HJ; Rubin, J | 1 |
| Santen, RJ | 2 |
| Andersen, AP; Andersen, KW; Bastholt, L; Brincker, H; Dombernowsky, P; Kamby, C; Loft, H; Mouridsen, HT; Rose, C; Skovgaard-Poulsen, H | 1 |
| Boucher, AE; Harvey, H; Henderson, IC; Lipton, A; Santen, RJ; Santner, SJ | 1 |
| Lê, MG; Masselot, J; Maugeri, G; May-Lévin, F; Sarrazin, D | 1 |
| Kamby, C; Rose, C | 1 |
| Gennatas, CS; Kalovidouris, A; Kouvaris, J; Papavasiliou, C; Paraskevas, GA; Trichopoulos, D | 1 |
| Bonadonna, G; Brambilla, C; Tancini, G; Zambetti, M | 1 |
| Nemoto, T | 1 |
| Benz, C; Hollander, C; Miller, B | 1 |
| Brodie, AM; Coombes, RC; Dowsett, M; Goss, P; Wing, LY | 1 |
| Bundred, NJ; Dale, BA; Eremin, O; Forrest, AP; Stewart, HJ | 1 |
| Coombes, RC; Easton, D; Goss, PE; Singh, D; Wilkinson, JR; Williams, JC | 1 |
| Dowsett, M; Harris, AL; Smith, IE; Stuart-Harris, R | 1 |
| Amoroso, D; Ardizzoni, A; Bertelli, G; Conte, PF; Falcone, A; Fusco, V; Gardin, G; Gulisano, M; Pronzato, P; Repetto, L | 1 |
| Paterson, AH | 1 |
| Donahoe, PK; Hutson, JM; MacLaughlin, DT | 1 |
| Lutz, D | 1 |
| Grisold, W; Lutz, D; Mamoli, B; Mokrusa, W; Weber, R | 1 |
| Hedley, DW; Levene, AL; Smith, IE; Stuart-Harris, R; Taylor, IW | 1 |
| Calman, K; Campbell-Ferguson, J; Habeshaw, T; Kaye, S; Macbeth, F; Milsted, R; Sangster, G; Smith, D | 1 |
| Alberto, P; Barrelet, L; Cavalli, F; Goldhirsch, A; Jungi, F; Kaplan, E; Martz, G; Mermillod, B; Obrecht, JP | 1 |
| Achterrath, W; Balleisen, L; Büchner, T; Hiddemann, W; Preusser, P; Urbanitz, D | 1 |
| Harris, AL | 1 |
| Howell, A; Ribeiro, G | 1 |
| Carter, RD; Muchmore, JH; Sutherland, CM | 1 |
| Macaulay, V; Smith, IE | 1 |
| Dahl, O; Kvinnsland, S; Lønning, PE | 1 |
| Ashley, S; Coombes, RC; Ford, HT; Gazet, JC; Nash, AG; Neville, AM; Powles, TJ | 1 |
| Bozek, T; Carr, L; Dowsett, M; Gazet, JC; Jeffcoate, SL; Kurkure, A; McKinna, JA; Smith, IE; Stuart-Harris, R | 1 |
| Coates, AS; Fox, RM; Kaye, SB; Tattersall, MH; Woods, RL | 1 |
| Boucher, AE; Dixon, RJ; Harvey, HA; Lipton, A; Santen, RJ; Shafik, AS; White, DS | 1 |
| Blumenschein, GR; Buzdar, AU; Legha, SS; Powell, KC | 1 |
| Dao, TL; Nemoto, T; Patel, JK | 1 |
| Murray, RM; Pitt, P | 2 |
| Ingle, JN | 1 |
| Carlström, K; Döberl, A; Pousette, A; Rannevik, G; Wilking, N | 1 |
| Smith, IE; Stuart-Harris, RC | 1 |
| Hayward, JL | 1 |
| Allison, RW; Furnival, CM; Lee, JF; Roberts, SJ | 1 |
| Døskeland, SO; Ekanger, R; Kvinnsland, S; Thorsen, T | 1 |
| Cikes, M | 1 |
| Mattheiem, W; Mouridsen, HT; Palshof, T; Paridaens, RJ; Rotmensz, N; Sylvester, RJ | 1 |
| Moiseenko, VM; Semiglazov, VF | 1 |
| Holland, JF; Perlow, LS | 1 |
| Carr, L; Ford, HT; Gazet, JC; Harmer, CL; Harris, AL; McKinna, JA; Morgan, M; Smith, IE; Stuart-Harris, R; White, H | 1 |
| Bezwoda, WR; Browde, S; Derman, DP; Goss, G; Lange, M | 1 |
| Dowsett, M; Harris, AL; Jeffcoate, SL; Smith, IE | 1 |
| Bernath, A; Boucher, A; Dixon, R; Harvey, HA; Lipton, A; Richards, G; Santen, RJ; Shafik, A; White, D | 2 |
| Forrest, AP | 1 |
| Schratter-Sehn, AU; Szepesi, T | 1 |
| Ford, HT; Gazet, JC; Harmer, CL; Harris, AL; McKinna, JA; Morgan, M; Parsons, CA; Smith, IE; Villardo, A; Walsh, G; White, H | 1 |
| Buchanan, R; Williams, C | 1 |
| Coombes, RC; Dowsett, M; Harris, AL; Jeffcoate, SL; McGarrick, GE; Smith, IE | 1 |
| Coombes, RC; Dady, P; Ford, HT; Gazet, JC; McCready, VR; Parsons, C; Powles, TJ | 1 |
| Dahl, O; Kvinnsland, S | 1 |
| Holdaway, IM | 1 |
| Campbell, JJ; Murray, R; Pepperell, RJ; Quinn, MA | 1 |
| Fox, RM; Kaye, SB; Tattersall, MH; Woods, RL | 1 |
| Ascoli, DM; Corkery, J; Gelman, RS; Henderson, IC; Hourihan, J; Leonard, RC; Salhanick, HA | 1 |
| Gazet, JC; Harris, AL; McKinna, JA; Morgan, M; Smith, IE | 1 |
| Coombes, RC; Gordon, C; Powles, TJ | 1 |
| Ahmann, DL; Edmonson, JH; Frytak, S; Green, SJ; Ingle, JN; Nichols, WC; Rubin, J | 1 |
| Blumenschein, GR; Buzdar, AU; Powell, KC | 1 |
| Coombes, RC; Ford, HT; Gazet, JC; Henk, M; Nash, AG; Neville, AM; Powles, TJ; Ratcliffe, WA; Rees, LH | 1 |
| Costanza, ME | 1 |
| Bamber, JC; Minasian, H | 1 |
| Duke, D; Greenway, B; Iqbal, MJ; Johnson, PJ; Pym, B; Williams, R | 1 |
| Harvey, H; Lipton, A; Santen, RJ; Wells, SA | 1 |
| Henderson, IC | 1 |
| Barash, NIu; Bershteĭn, LM; Bozhok, AA; Ivanov, VG; Ivanova, OA; Moiseenko, VM; Semiglazov, VF; Tsyrlina, EV | 1 |
| Botella, J; Delansorne, R; Duc, I; Duranti, E; Paris, J; Viader, V | 1 |
| Ahlgren, JD; Alt, D; Ellison, NM; Gottlieb, RJ; Laluna, F; Lokich, JJ; Sinclair, PR; Ueno, W; Wampler, GL; Yeung, KY | 1 |
| Espié, M | 2 |
| Stalfelt, AM | 1 |
| Ayme, Y; Carton, M; Daban, A; Delozier, T; Fargeot, P; Ferri, L; Fumoleau, P; Garcia-Giralt, E; Gorins, A; Omodei Zorini, C | 1 |
| Haase, D; Hehlmann, R; Hild, F; Lengfelder, E; Simon, M | 1 |
| Lönn, S; Lönn, U; Stenkvist, B | 2 |
| Dengler, R; Emmerich, B; Walther, JU | 1 |
| Amoroso, D; Bertelli, G; Gallotti, P; Monzeglio, C; Pronzato, P; Queirolo, P; Rosso, M; Rosso, R; Rubagotti, A; Sertoli, MR | 1 |
| Bertelli, G; Pronzato, P; Rosso, M | 1 |
| Andersen, JW; Cummings, FJ; Davis, TE; Gale, KE; Horton, J; Mansour, EG; Smith, TJ; Tormey, DC; Wolter, JM | 1 |
| Miller, WR; Mullen, P | 1 |
| Ayme, Y; Carton, M; Daban, A; Delozier, T; Fargeot, P; Fumoleau, P; Garcia-Giralt, E; Gorins, A; Guerin, D; Guerin, R | 1 |
| Bozhok, AA; Ivanov, VG; Ivanova, OA; Moiseenko, VM; Semiglazov, VF; Tsyrlina, EV | 1 |
| Gelber, RD; Goldhirsch, A | 1 |
| Ingelman-Sundberg, H; Lönn, S; Lönn, U; Nilsson, B; Stenkvist, B | 1 |
| Anker, G; Lien, EA; Lønning, PE; Refsum, H; Ueland, PM | 1 |
| Barash, NI; Bozhok, AA; Ivanov, VG; Ivanova, OA; Migmanova, NS; Moiseenko, VM; Popova, RT; Seleznev, IK; Semiglazov, VF; Tsyrlina, EV | 1 |
| Cao, B; Zhang, X | 1 |
| Buzdar, AU; Roseman, BJ; Singletary, SE | 1 |
| Anderson, ED; Anderson, TJ; Cameron, DA; Chetty, U; Forrest, AP; Hawkins, RA; Leonard, RC; Levack, P | 1 |
| Blamey, RW; Cheung, KL; Ellis, IO; Elston, CW; Nicholson, RI; Pinder, SE; Robertson, JF; Willsher, PC | 1 |
| Bühler, H; Hundertmark, S; Ragosch, V; Rudolf, M; Weitzel, HK | 1 |
| Kaufmann, M | 1 |
| Bonneterre, J; Leriche, N | 1 |
| Friedrichs, K; Jänicke, F | 1 |
| Rao, AJ; Shanker, YG; Shetty, UP | 1 |
| Busch, R; Dengler, R; Eger, G; Emmerich, B; Münstermann, U; Plewan, A | 1 |
| Diehl, V; Dimski, T; Lathan, B; Pantke, B; Schinköthe, T; Staib, P; Voliotis, D; Wiedenmann, S | 1 |
| Ragaz, J | 1 |
| Harvey, HA; Santen, RJ | 1 |
| Andersen, J; Andersson, M; Bastholt, L; Christensen, IJ; Dombernowsky, P; Kamby, C; Mouridsen, HT; Munkholm, P; Møller, KA; Rose, C | 1 |
| Branković-Magić, MV; Mitrovic, LB; Nesković-Konstantinović, ZB; Nikolić-Vukosavljević, DB; Spuzić, I | 1 |
| Bonneterre, J; Mauriac, L | 1 |
| Bhat, KP; Christov, K; Hawthorne, ME; Kelloff, GJ; Kopelovich, L; Mehta, RG; Mehta, RR; Pezzuto, JM; Steele, VE | 1 |
| Amoroso, D; Boccardo, F; Caroti, C; Cruciani, G; Farris, A; Mesiti, M; Mustacchi, G; Romeo, D; Rubagotti, A; Schieppati, G; Villa, E | 1 |
| Buzdar, AU | 1 |
| Benedetto, C; De Nicola, B; Ferraris, F; Genta, F; Piccinno, R; Porpiglia, M; Vicelli, R | 1 |
| Hill, J; Moore, H | 1 |
| Ceccherini, R; Dellach, C; Leita, ML; Milani, S; Muggia, M; Mustacchi, G | 1 |
| Goetz, M; Heussel, H; Hiddemann, W; Schiel, X; Steinmetz, T; Weiss, M | 1 |
| Fridrik, M; Gnant, M; Haider, K; Hausmaninger, H; Jakesz, R; Kubista, E; Kwasny, W; Menzel, C; Mlineritsch, B; Samonigg, H; Schmid, M; Seifert, M; Steger, G; Steindorfer, P; Stierer, M; Taucher, S; Tausch, C; Wette, V | 1 |
| Vogel, CL | 1 |
| Rose, C | 1 |
| Haferlach, C; Haferlach, T; Schnittger, S; Weisser, M | 1 |
| Fox, J; Hamad, A; Kluk, M; Park, M; Turner, JE | 1 |
| Prowell, TM; Stearns, V | 1 |
| Dadak, C; Gnant, M; Greil, R; Hofbauer, F; Jakesz, R; Kubista, E; Kwasny, W; Mlineritsch, B; Renner, K; Rücklinger, E; Samonigg, H; Schmid, M; Stierer, M; Tausch, C | 1 |
| Dietze, O; Filipits, M; Gnant, MF; Greil, R; Grill, R; Huynh, A; Jakesz, R; Kwasny, W; Lax, S; Lehnert, M; Rudas, M; Schippinger, W; Singer, C; Stierer, M; Stiglbauer, W | 1 |
| Balic, M; Dubsky, P; Fesl, C; Fitzal, F; Gnant, M; Greil, R; Hofbauer, F; Jakesz, R; Kwasny, W; Mlineritsch, B; Moik, M; Pfeiler, G; Ploner, F; Renner, K; Samonigg, H; Sandbichler, P; Seifert, M; Selim, U; Singer, C; Steger, GG; Stöger, H | 1 |
| Aul, C; Balleisen, L; Beelen, D; Berdel, WE; Braess, J; Büchner, T; Eimermacher, H; Gale, RP; Giagounidis, A; Görlich, D; Grüneisen, A; Haferlach, C; Haferlach, T; Hehlmann, R; Heinecke, A; Hiddemann, W; Kern, W; Köpcke, W; Krug, U; Lengfelder, E; Ludwig, WD; Maschmeyer, G; Müller-Tidow, C; Rasche, H; Reichle, A; Sauerland, MC; Schliemann, C; Schnittger, S; Serve, H; Spiekermann, K; Staib, P; Stelljes, M; Thiel, E; Wörmann, BJ | 1 |
30 review(s) available for aminoglutethimide and tamoxifen
| Article | Year |
|---|---|
Adjuvant endocrine therapy of breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Middle Aged; Ovariectomy; Ovary; Tamoxifen; Testosterone | 1992 |
[Hormone therapy of neoplasms].
Topics: Adenoma, Islet Cell; Aminoglutethimide; Breast Neoplasms; Female; Fluoxymesterone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Pancreatic Neoplasms; Prostatic Neoplasms; Tamoxifen | 1991 |
[Adjuvant hormone therapy of primary breast cancer. Review of the literature].
Topics: Amenorrhea; Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Delayed-Action Preparations; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Tamoxifen | 1991 |
[Hormonal treatment of breast tumor].
Topics: Adrenalectomy; Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Drug Administration Schedule; Female; Gonadotropin-Releasing Hormone; Humans; Hypophysectomy; Neoplasms, Hormone-Dependent; Ovariectomy; Tamoxifen | 1990 |
Advances in the therapy of acute nonlymphocytic leukemia.
Topics: Aminoglutethimide; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Danazol; Humans; Leukemia, Myeloid, Acute; Tamoxifen | 1989 |
Tamoxifen therapy of metastatic breast cancer.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Random Allocation; Tamoxifen | 1987 |
Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adult; Aged; Aminoglutethimide; Androgens; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Estrogens; Female; Humans; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Middle Aged; Rats; Tamoxifen | 1986 |
Fundamental research leading to improved endocrine therapy for breast cancer.
Topics: Adrenal Cortex Hormones; Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Combined Modality Therapy; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Menopause; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Ovariectomy; Progestins; Receptors, Estrogen; Receptors, Progesterone; RNA, Neoplasm; Tamoxifen | 1987 |
Could aminoglutethimide replace adrenalectomy?
Topics: Adrenal Cortex; Adrenalectomy; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Estrogens; Female; Humans; Menopause; Neoplasms, Hormone-Dependent; Ovary; Steroids; Tamoxifen | 1985 |
Aminoglutethimide in the treatment of advanced breast cancer.
Topics: Adrenalectomy; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; Drug Therapy, Combination; Estradiol; Estrone; Female; Glucocorticoids; Humans; Hydrocortisone; Hypophysectomy; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1984 |
Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review.
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Aminoglutethimide; Androgens; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Estrogens; Female; Humans; Hydrocortisone; Hypophysectomy; Ovary; Receptors, Estrogen; Tamoxifen | 1981 |
[Chemical adrenalectomy induced by aminoglutethimide in the treatment of breast cancer. A review].
Topics: Adrenal Glands; Adrenalectomy; Aminoglutethimide; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Hydrocortisone; Hypophysectomy; Random Allocation; Tamoxifen | 1983 |
[Hormone therapy of patients with breast cancer].
Topics: Adrenalectomy; Aminoglutethimide; Breast Neoplasms; Castration; Combined Modality Therapy; Drug Resistance; Estrogens; Female; Hormones; Humans; Hypophysectomy; Levodopa; Mastectomy; Menopause; Progestins; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1984 |
Chemotherapy of breast cancer.
Topics: Adrenalectomy; Alkylating Agents; Aminoglutethimide; Androgens; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Estrogens; Female; Fluorouracil; Humans; Immunotherapy; Methotrexate; Naphthacenes; Pituitary Hormone-Releasing Hormones; Progestins; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Vinca Alkaloids | 1984 |
Beatson: hormones and the management of breast cancer.
Topics: Adult; Aging; Aminoglutethimide; Breast; Breast Neoplasms; Estrogens; Female; Hormones; Humans; Menopause; Menstruation; Middle Aged; Ovary; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Risk; Tamoxifen | 1982 |
[Hormones and tumor therapy: current clinical status and future developments in endocrine therapy of breast cancer].
Topics: Adrenal Cortex Hormones; Adrenalectomy; Aminoglutethimide; Androgens; Breast Neoplasms; Castration; Cyproterone; Estrogens; Female; Gonadotropins; Hormones; Humans; Hydrocortisone; Hypophysectomy; Menopause; Neoplasm Metastasis; Progesterone; Tamoxifen | 1982 |
[Hormonal therapy of breast cancer].
Topics: Aminoglutethimide; Breast Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone Acetate; Ovariectomy; Tamoxifen | 1994 |
Endocrine therapies of breast cancer.
Topics: Aminoglutethimide; Androgens; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Endocrine Glands; Enzyme Inhibitors; Estrogen Antagonists; Estrogens; Female; Hormone Antagonists; Humans; Progestins; Radiography; Tamoxifen | 1996 |
Effects of hormones on the plasma levels of the atherogenic amino acid homocysteine.
Topics: Aminoglutethimide; Antineoplastic Agents, Hormonal; Arteriosclerosis; Breast Neoplasms; Cardiovascular Diseases; Cholesterol; Coronary Disease; Estrogen Antagonists; Female; Homocysteine; Humans; Male; Myocardial Infarction; Tamoxifen | 1997 |
Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.
Topics: Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Tamoxifen; Triazoles | 1997 |
A review of endocrine options for the treatment of advanced breast cancer.
Topics: Aminoglutethimide; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; History, 20th Century; Humans; Ovariectomy; Postmenopause; Premenopause; Progestins; Tamoxifen | 1997 |
[Progestational agents and bone metastasis in breast cancer].
Topics: Aminoglutethimide; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Melengestrol Acetate; Survival Analysis; Tamoxifen | 1997 |
[Aromatase inhibitors--new possibilities in treatment of breast carcinoma].
Topics: Aminoglutethimide; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Enzyme Inhibitors; Female; Humans; Neoplasms, Hormone-Dependent; Tamoxifen | 1998 |
Status of aromatase inhibitors in relation to other breast cancer treatment modalities.
Topics: Aminoglutethimide; Anticarcinogenic Agents; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Enzyme Inhibitors; Estrogen Antagonists; Humans; Neoplasms, Hormone-Dependent; Selective Estrogen Receptor Modulators; Tamoxifen | 1999 |
Use of aromatase inhibitors in breast carcinoma.
Topics: Adult; Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Drug Design; Drug Interactions; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Premenopause; Tamoxifen; Triazoles | 1999 |
A summary of second-line randomized studies of aromatase inhibitors.
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Drug Tolerance; Enzyme Inhibitors; Estrogen Receptor Modulators; Fadrozole; Female; Humans; Letrozole; Megestrol Acetate; Neoplasms, Hormone-Dependent; Nitriles; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles | 2001 |
[The role of aromatase inhibitors in the treatment of breast neoplasms. An evaluation of clinical efficacy and the tolerability profile].
Topics: Adult; Aminoglutethimide; Anastrozole; Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Enzyme Inhibitors; Female; Follow-Up Studies; Forecasting; Humans; Letrozole; Middle Aged; Nitriles; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Time Factors; Triazoles | 2002 |
Aromatase inhibitors in breast cancer: current and evolving roles.
Topics: Aminoglutethimide; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Enzyme Inhibitors; Estrogens; Female; Humans; Neoplasms, Hormone-Dependent; Postmenopause; Tamoxifen | 2002 |
Update on the current use of hormonals as therapy in advanced breast cancer.
Topics: Aminoglutethimide; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Estrogen Antagonists; Humans; Neoplasms, Hormone-Dependent; Tamoxifen; Toremifene | 2003 |
A comparison of the efficacy of aromatase inhibitors in second-line treatment of metastatic breast cancer.
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Letrozole; Megestrol Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Receptors, Estrogen; Tamoxifen; Triazoles | 2003 |
53 trial(s) available for aminoglutethimide and tamoxifen
| Article | Year |
|---|---|
Primary systemic therapy for operable breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Combined Modality Therapy; Female; Goserelin; Humans; Lymphatic Metastasis; Middle Aged; Ovariectomy; Tamoxifen | 1991 |
Second line hormonal therapy with aminoglutethimide in metastatic breast cancer.
Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Aminoglutethimide; Breast Neoplasms; Estrogen Antagonists; Female; Humans; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1990 |
Megestrol acetate versus aminoglutethimide for metastatic breast cancer.
Topics: Aged; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Female; Follow-Up Studies; Humans; Megestrol; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1989 |
Tamoxifen therapy of metastatic breast cancer.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Random Allocation; Tamoxifen | 1987 |
Randomized trial comparing aminoglutethimide with high-dose medroxyprogesterone acetate in therapy for advanced breast carcinoma.
Topics: Aminoglutethimide; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Random Allocation; Tamoxifen; Time Factors | 1988 |
Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Menopause; Middle Aged; Random Allocation; Tamoxifen | 1988 |
Endocrine therapy of advanced breast cancer.
Topics: Adrenalectomy; Aminoglutethimide; Breast Neoplasms; Clinical Trials as Topic; Estrogens; Female; Hormones; Humans; Menopause; Ovariectomy; Progestins; Random Allocation; Receptors, Estrogen; Tamoxifen | 1988 |
Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adult; Aged; Aminoglutethimide; Androgens; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Estrogens; Female; Humans; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Middle Aged; Rats; Tamoxifen | 1986 |
Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Hydrocortisone; Middle Aged; Neoplasm Metastasis; Random Allocation; Tamoxifen; Time Factors | 1986 |
Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
Topics: Adrenalectomy; Aminoglutethimide; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Estrogens; Female; Humans; Random Allocation; Sulfatases; Tamoxifen | 1986 |
Combined endocrine treatment of postmenopausal patients with advanced breast cancer. A randomized trial of tamoxifen vs. tamoxifen plus aminoglutethimide and hydrocortisone.
Topics: Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Hydrocortisone; Menopause; Neoplasm Metastasis; Random Allocation; Research Design; Statistics as Topic; Tamoxifen | 1986 |
Inhibition of aromatase as treatment of breast carcinoma in postmenopausal women.
Topics: Aminoglutethimide; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Dose-Response Relationship, Drug; Estrogens; Female; Humans; Menopause; Obesity; Random Allocation; Tamoxifen | 1987 |
Metastatic pattern and response to endocrine therapy in human breast cancer.
Topics: Aminoglutethimide; Breast Neoplasms; Diethylstilbestrol; Female; Fluoxymesterone; Humans; Medroxyprogesterone; Menopause; Neoplasm Metastasis; Tamoxifen | 1986 |
A randomized phase II trial of aminoglutethimide and hydrocortisone versus combined aminoglutethimide, hydrocortisone and fluoxymesterone in advanced breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Female; Fluoxymesterone; Humans; Hydrocortisone; Middle Aged; Random Allocation; Tamoxifen | 1987 |
A randomised trial of tamoxifen versus tamoxifen with aminoglutethimide in post-menopausal women with advanced breast cancer.
Topics: Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Menopause; Middle Aged; Random Allocation; Tamoxifen | 1985 |
A clinical trial of aminoglutethimide in advanced postmenopausal breast carcinoma: low response in patients previously treated with medroxyprogesterone.
Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Medroxyprogesterone; Menopause; Middle Aged; Tamoxifen | 1985 |
Could aminoglutethimide replace adrenalectomy?
Topics: Adrenal Cortex; Adrenalectomy; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Estrogens; Female; Humans; Menopause; Neoplasms, Hormone-Dependent; Ovary; Steroids; Tamoxifen | 1985 |
Treatment of disseminated breast cancer with tamoxifen, aminoglutethimide, hydrocortisone, and danazol, used in combination or sequentially.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Danazol; Female; Humans; Hydrocortisone; Menopause; Receptors, Estrogen; Tamoxifen | 1984 |
Additive hormonal therapy in women with advanced breast cancer.
Topics: Aminoglutethimide; Androgens; Breast Neoplasms; Clinical Trials as Topic; Danazol; Drug Therapy, Combination; Estrogens; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Humans; Hypophysectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Random Allocation; Tamoxifen | 1984 |
Aminoglutethimide in the treatment of advanced breast cancer.
Topics: Adrenalectomy; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; Drug Therapy, Combination; Estradiol; Estrone; Female; Glucocorticoids; Humans; Hydrocortisone; Hypophysectomy; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1984 |
Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review.
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Aminoglutethimide; Androgens; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Estrogens; Female; Humans; Hydrocortisone; Hypophysectomy; Ovary; Receptors, Estrogen; Tamoxifen | 1981 |
[Chemical adrenalectomy induced by aminoglutethimide in the treatment of breast cancer. A review].
Topics: Adrenal Glands; Adrenalectomy; Aminoglutethimide; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Hydrocortisone; Hypophysectomy; Random Allocation; Tamoxifen | 1983 |
Currently active protocols in the EORTC Breast Cancer Cooperative Group.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Metastasis; Receptors, Estrogen; Tamoxifen | 1984 |
A randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
Topics: Aminoglutethimide; Breast Neoplasms; Castration; Clinical Trials as Topic; Female; Humans; Menopause; Neoplasm Metastasis; Receptors, Estrogen; Tamoxifen | 1982 |
Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.
Topics: Adult; Aged; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Drug Resistance; Female; Humans; Male; Menopause; Middle Aged; Random Allocation; Tamoxifen | 1981 |
The treatment of metastatic breast cancer with aminoglutethimide.
Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Clinical Trials as Topic; Drug Resistance; Female; Humans; Middle Aged; Tamoxifen | 1981 |
Tamoxifen and aminoglutethimide in advanced breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Binding, Competitive; Breast Neoplasms; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Estrogens; Female; Humans; Middle Aged; Random Allocation; Receptors, Estrogen; Tamoxifen | 1982 |
Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.
Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Menopause; Middle Aged; Neoplasm Staging; Prognosis; Random Allocation; Sleep Stages; Tamoxifen | 1982 |
Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
Topics: Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Castration; Clinical Trials as Topic; Drug Administration Schedule; Estrogens; Female; Humans; Menopause; Middle Aged; Nausea; Random Allocation; Tamoxifen | 1982 |
Clinical trial of multiple endocrine therapy for metastatic and locally advanced breast cancer with tamoxifen-aminoglutethimide-danazol compared to tamoxifen used alone.
Topics: Aminoglutethimide; Breast Neoplasms; Clinical Trials as Topic; Danazol; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Pregnadienes; Probability; Random Allocation; Tamoxifen | 1982 |
Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure.
Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Middle Aged; Nausea; Neoplasm Recurrence, Local; Prognosis; Random Allocation; Sleep Stages; Tamoxifen | 1982 |
Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program.
Topics: Adenocarcinoma; Aminoglutethimide; Carcinoma; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Megestrol; Megestrol Acetate; Ovarian Neoplasms; Palliative Care; Tamoxifen | 1993 |
Quality of life during induction treatment of acute myeloid leukaemia. A comparison of three intensive chemotherapy regimens using three instruments for quality of life assessment.
Topics: Acute Disease; Adolescent; Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Danazol; Female; Humans; Interviews as Topic; Karnofsky Performance Status; Leukemia, Myeloid; Longitudinal Studies; Male; Methods; Middle Aged; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Surveys and Questionnaires; Tamoxifen | 1994 |
[2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients].
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Breast Neoplasms; Drug Resistance; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Tamoxifen; Time Factors | 1994 |
Second-line hormonotherapy for breast cancer. Uselessness of first-line continuation.
Topics: Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Hydrocortisone; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Survival Analysis; Tamoxifen | 1993 |
A randomized trial on tamoxifen continuation during second-line hormone therapy in breast cancer.
Topics: Aminoglutethimide; Breast Neoplasms; Female; Humans; Hydrocortisone; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone; Survival Analysis; Tamoxifen | 1993 |
Hormonal treatment for metastatic breast cancer. An Eastern Cooperative Oncology Group Phase III trial comparing aminoglutethimide to tamoxifen.
Topics: Adrenalectomy; Aminoglutethimide; Breast Neoplasms; Female; Humans; Tamoxifen | 1994 |
Second and third line hormonotherapy in advanced post-menopausal breast cancer: a multicenter randomized trial comparing medroxyprogesterone acetate with aminoglutethimide in patients who have become resistant to tamoxifen.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Breast Neoplasms; Drug Resistance; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prospective Studies; Tamoxifen; Time Factors; Treatment Outcome | 1992 |
[Effectiveness of adjuvant hormone therapy in breast cancer].
Topics: Aminoglutethimide; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Diethylstilbestrol; Disease-Free Survival; Female; Humans; Survival Analysis; Tamoxifen; Treatment Outcome | 1996 |
[Postoperative hormone therapy of breast cancer (analysis of overall survival)].
Topics: Adult; Aminoglutethimide; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Dienestrol; Estrogens, Non-Steroidal; Female; Humans; Middle Aged; Neoplasm Staging; Survival Analysis; Tamoxifen; Treatment Outcome | 1996 |
Exploration for drug therapy in endometrial carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinoma, Squamous Cell; Double-Blind Method; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Middle Aged; Tamoxifen | 1996 |
Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Goserelin; Humans; Hydrocortisone; Lymphatic Metastasis; Middle Aged; Neoplasms, Hormone-Dependent; Ovariectomy; Prednisone; Preoperative Care; Tamoxifen; Treatment Outcome; Vincristine | 1997 |
Prognosis in adult AML is precisely predicted by the DISC-assay using the chemosensitivity-index Ci.
Topics: Adult; Aminoglutethimide; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cell Survival; Cytarabine; Danazol; Drug Screening Assays, Antitumor; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Leukemia, Myeloid, Acute; Predictive Value of Tests; Prognosis; Prospective Studies; Regression Analysis; Remission Induction; Survival Analysis; Tamoxifen; Vidarabine | 1999 |
Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Drug Synergism; Enzyme Inhibitors; Female; Fluoxymesterone; Humans; Hydrocortisone; Life Tables; Neoplasm Metastasis; Neoplasm Proteins; Salvage Therapy; Selective Estrogen Receptor Modulators; Survival Analysis; Tamoxifen; Treatment Outcome | 2000 |
Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction.
Topics: Adult; Aminoglutethimide; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; ErbB Receptors; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Ovariectomy; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Survival Analysis; Tamoxifen; Treatment Outcome | 2000 |
Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative study.
Topics: Aged; Aminoglutethimide; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Drug Resistance; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; Italy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Postmenopause; Receptors, Estrogen; Survival Rate; Tamoxifen | 2001 |
A phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Neoplasms; Breast Neoplasms; Cisplatin; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Megestrol Acetate; Middle Aged; Neoplasm Staging; Probability; Risk Assessment; Soft Tissue Neoplasms; Survival Analysis; Tamoxifen; Vinblastine; Vinorelbine | 2002 |
Elevation of soluble tumor necrosis factor receptor II in non-febrile patients with acute myeloid leukemia.
Topics: Adult; Aged; Aminoglutethimide; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Danazol; Etanercept; Female; Fever; Humans; Immunoglobulin G; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Neutropenia; Prospective Studies; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type II; Tamoxifen | 2002 |
Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.
Topics: Aged; Aminoglutethimide; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Austria; Breast Neoplasms; Chemotherapy, Adjuvant; Disease Progression; Drug Administration Schedule; Estrogen Receptor Modulators; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Survival Analysis; Tamoxifen; Treatment Outcome | 2003 |
Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Austria; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Lymphatic Metastasis; Male; Middle Aged; Nitriles; Odds Ratio; Postmenopause; Proportional Hazards Models; Prospective Studies; Receptors, Estrogen; Receptors, Progesterone; Research Design; Tamoxifen; Treatment Outcome; Triazoles | 2007 |
Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclin D1; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Goserelin; Humans; Methotrexate; Middle Aged; Prognosis; Receptors, Cytoplasmic and Nuclear; Recurrence; Tamoxifen; Treatment Outcome | 2008 |
Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Body Mass Index; Breast Neoplasms; Female; Humans; Middle Aged; Overweight; Postmenopause; Prospective Studies; Receptors, Cell Surface; Tamoxifen; Treatment Outcome | 2013 |
Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia.
Topics: Adult; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Danazol; Disease-Free Survival; Granulocyte Colony-Stimulating Factor; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Stem Cell Transplantation; Survival Rate; Tamoxifen; Transplantation, Autologous; Treatment Outcome; Young Adult | 2016 |
115 other study(ies) available for aminoglutethimide and tamoxifen
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effect of some antiestrogens and aromatase inhibitors on androgen induced sexual behavior in castrated male rats.
Topics: Aminoglutethimide; Androstenedione; Animals; Castration; Clomiphene; Drug Interactions; Ejaculation; Ethamoxytriphetol; Male; Metyrapone; Rats; Sexual Behavior, Animal; Tamoxifen; Testosterone; Time Factors | 1976 |
Disruption of ovarian development in alligator embryos treated with an aromatase inhibitor.
Topics: Alligators and Crocodiles; Aminoglutethimide; Androstenedione; Animals; Aromatase Inhibitors; Cyproterone; Cyproterone Acetate; Estradiol; Fadrozole; Female; Imidazoles; Male; Nitriles; Ovary; Tamoxifen; Testis | 1992 |
[Aminoglutethimide and aminoglutethimide+tamoxifen treatment for advanced breast cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aminoglutethimide; Androstenedione; Breast Neoplasms; Drug Evaluation; Drug Therapy, Combination; Estrone; Female; Humans; Middle Aged; Survival Rate; Tamoxifen | 1992 |
Investigations of droloxifene and other hormonal manipulations on N-nitrosomethylurea-induced rat mammary tumours. 2. Influence on oestrogen receptor.
Topics: Aminoglutethimide; Animals; Antineoplastic Agents; Estradiol; Estrogen Antagonists; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Ovariectomy; Rats; Receptors, Estrogen; Tamoxifen | 1992 |
Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients.
Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Buserelin; Cortisone; Female; Goserelin; Humans; Insulin-Like Growth Factor I; Menopause; Middle Aged; Tamoxifen | 1992 |
[Growth inhibition of MCF-7 human breast cancer cells by aromatase inhibitors].
Topics: Aminoglutethimide; Aromatase Inhibitors; Breast Neoplasms; Cyproterone; Cyproterone Acetate; Female; Humans; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 1991 |
[Reflexions on hormone therapy of cancer of the breast].
Topics: Aminoglutethimide; Androgens; Breast Neoplasms; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Ovariectomy; Tamoxifen | 1991 |
pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response.
Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Menopause; Neoplasm Proteins; Prognosis; Proteins; Receptors, Estrogen; Tamoxifen; Trefoil Factor-1; Tumor Suppressor Proteins | 1991 |
Modulatory influences of tamoxifen, tocopherol, retinyl acetate, aminoglutethimide, ergocryptine and selenium on DMBA-induced initiation of mammary carcinogenesis in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoglutethimide; Animals; Diterpenes; Drug Interactions; Ergolines; Female; Mammary Neoplasms, Experimental; Rats; Retinyl Esters; Selenium; Tamoxifen; Vitamin A; Vitamin E | 1990 |
[Hormonal control of disseminated breast cancer].
Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Delayed-Action Preparations; Estrogen Antagonists; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1990 |
Combination of tamoxifen, aminoglutethimide, danazol and medroxyprogesterone acetate in advanced breast cancer.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Danazol; Female; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1990 |
Endocrine and clinical aspects of new compounds for treatment of hormone-related cancer in gynecology.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Neoplasms, Hormone-Dependent; Tamoxifen | 1990 |
Changing response of clonogenic myeloid leukemia blasts to granulocyte-macrophage colony-stimulating factor (GM-CSF) during anti-leukemic therapy--a case report on the basis of a clinical phase II trial.
Topics: Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Colony-Stimulating Factors; Danazol; DNA, Neoplasm; Drug Evaluation; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Substances; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Male; Tamoxifen | 1990 |
Relationship between tumour aromatase activity, tumour characteristics and response to therapy.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Aromatase; Breast Neoplasms; Estrogens; Female; Humans; Prognosis; Receptors, Estrogen; Tamoxifen; Testosterone; Tritium | 1990 |
Response to second-line hormone treatment for advanced breast cancer. Predictive value of ploidy determination.
Topics: Aminoglutethimide; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Diploidy; DNA, Neoplasm; Female; Flow Cytometry; Humans; Medroxyprogesterone; Neoplasm Recurrence, Local; Ploidies; Probability; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1990 |
Decreased serum concentrations of tamoxifen and its metabolites induced by aminoglutethimide.
Topics: Acetylation; Aged; Aminoglutethimide; Cortisone; Drug Interactions; Female; Glucuronates; Humans; Middle Aged; Tamoxifen | 1990 |
Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy.
Topics: Aminoglutethimide; Antibodies, Monoclonal; Breast Neoplasms; Combined Modality Therapy; Dextrans; Female; Histocytochemistry; Humans; Immunoenzyme Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prognosis; Receptors, Estrogen; Staining and Labeling; Tamoxifen | 1986 |
Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Drug Administration Schedule; ErbB Receptors; Female; Follow-Up Studies; Humans; Hydrocortisone; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Prognosis; Receptors, Estrogen; Tamoxifen | 1989 |
Cytochemical maturation index for the prognostication of adult acute nonlymphocytic leukaemia.
Topics: Adult; Age Factors; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cell Differentiation; Cell Survival; Danazol; Esterases; Humans; Leukemia, Myeloid, Acute; Middle Aged; Peroxidases; Prognosis; Remission Induction; Tamoxifen | 1989 |
Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.
Topics: Aminoglutethimide; Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Receptors, Estrogen; Tamoxifen | 1989 |
[Experimental multihormone therapy on human breast carcinomas grown in nude mice].
Topics: Aminoglutethimide; Animals; Drug Therapy, Combination; Estrogens; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Tamoxifen | 1989 |
[Current status of hormonotherapy of metastatic cancer of the breast].
Topics: Aminoglutethimide; Androgens; Breast Neoplasms; Estrogens; Female; Humans; Hydrocortisone; Medroxyprogesterone; Menopause; Ovariectomy; Tamoxifen | 1989 |
Immunohistochemical estrogen receptor determination in paraffin-embedded tissue. Prediction of response to hormonal treatment in advanced breast cancer.
Topics: Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Diethylstilbestrol; Female; Fluoxymesterone; Humans; Immunohistochemistry; Menopause; Middle Aged; Neoplasm Recurrence, Local; Paraffin; Receptors, Estrogen; Survival Analysis; Tamoxifen | 1989 |
Agranulocytosis induced by aminoglutethimide.
Topics: Aged; Agranulocytosis; Aminoglutethimide; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Drug Therapy, Combination; Female; Humans; Tamoxifen | 1988 |
[Dosage and modulation of cutaneous steroid receptors during antihormonal therapy in a case of Stewart-Treves syndrome].
Topics: Adenocarcinoma; Aged; Aminoglutethimide; Breast Neoplasms; Female; Humans; Immunoenzyme Techniques; Mastectomy, Modified Radical; Radioligand Assay; Receptors, Cell Surface; Skin Neoplasms; Syndrome; Tamoxifen | 1988 |
Aminoglutethimide in advanced breast cancer.
Topics: Adult; Aged; Alkaline Phosphatase; Aminoglutethimide; Breast Neoplasms; Female; gamma-Glutamyltransferase; Humans; Menopause; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1985 |
Acute leukaemia during pregnancy.
Topics: Adult; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Danazol; Female; Humans; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Tamoxifen | 1987 |
Hormonal treatment of disseminated male breast cancer.
Topics: Adult; Aminoglutethimide; Androgen Antagonists; Antineoplastic Agents; Breast Neoplasms; Castration; Cyproterone; Cyproterone Acetate; Estrogens; Hormones; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Tamoxifen; Time Factors | 1985 |
[Value of hormone therapy in metastasizing breast cancer].
Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Ovariectomy; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1985 |
Experimental combined hormone therapy on human breast carcinomas serially transplanted into nude mice.
Topics: Adult; Aminoglutethimide; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Estradiol; Female; Humans; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Organ Size; Tamoxifen; Transplantation, Heterologous; Uterus | 1986 |
Endocrine treatment of breast cancer: effects upon intratumoral estrone sulfate metabolism and peripheral steroid levels.
Topics: Aminoglutethimide; Breast Neoplasms; Danazol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Administration Schedule; Estrogens; Estrone; Female; Humans; Pregnadienes; Sex Hormone-Binding Globulin; Tamoxifen | 1986 |
[Endocrine therapy of breast cancer].
Topics: Aminoglutethimide; Antibodies, Monoclonal; Breast Neoplasms; Combined Modality Therapy; Female; Hormones; Humans; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1987 |
CGS 16949A, a new nonsteroidal aromatase inhibitor: effects on hormone-dependent and -independent tumors in vivo.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoglutethimide; Animals; Aromatase Inhibitors; Body Weight; Cell Line; Drug Screening Assays, Antitumor; Fadrozole; Female; Imidazoles; Mammary Neoplasms, Experimental; Nitriles; Rats; Tamoxifen | 1988 |
On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer.
Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Tamoxifen | 1987 |
[Which hormone therapy should be used in advanced breast carcinoma in males?].
Topics: Adenocarcinoma; Aged; Aminoglutethimide; Axilla; Breast Neoplasms; Dexamethasone; Drug Evaluation; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Tamoxifen; Testolactone; Testosterone Congeners | 1988 |
Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifen.
Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Receptors, Cell Surface; Tamoxifen | 1985 |
[Recent progress in endocrine therapy of patients with breast cancer].
Topics: Aminoglutethimide; Breast Neoplasms; Estrogen Antagonists; Female; Humans; Pituitary Hormone-Releasing Hormones; Tamoxifen | 1988 |
[Endocrine therapy in breast carcinoma].
Topics: Adrenal Cortex Hormones; Adrenalectomy; Adult; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Humans; Hypophysectomy; Middle Aged; Ovariectomy; Progestins; Tamoxifen | 1988 |
Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Breast Neoplasms; ErbB Receptors; Female; Humans; Hydrocortisone; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Receptors, Estrogen; Tamoxifen; Time Factors | 1988 |
DNA aneuploidies in adult patients with acute myeloid leukemia. Incidence and relation to patient characteristics and morphologic subtypes.
Topics: Adolescent; Adult; Age Factors; Aged; Aminoglutethimide; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Danazol; Flow Cytometry; Humans; L-Lactate Dehydrogenase; Leukemia, Myeloid, Acute; Leukocyte Count; Middle Aged; Preleukemia; Tamoxifen | 1986 |
Clinical studies with aminoglutethimide in advanced breast carcinoma.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Drug Therapy, Combination; Estrogen Antagonists; Female; Humans; Hydrocortisone; Neoplasms, Hormone-Dependent; Random Allocation; Tamoxifen | 1986 |
[Factors linked to the development of pleuro-pulmonary metastases in breast cancer. Preliminary study].
Topics: Aminoglutethimide; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Pleural Neoplasms; Prognosis; Risk; Tamoxifen | 1987 |
Aminoglutethimide in postmenopausal breast cancer refractory to multiple hormonal and cytostatic treatments.
Topics: Adrenalectomy; Adult; Aged; Aminoglutethimide; Breast Neoplasms; Female; Humans; Hydrocortisone; Menopause; Middle Aged; Receptors, Estrogen; Tamoxifen | 1987 |
Endocrine therapy of metastatic breast cancer.
Topics: Aminoglutethimide; Breast Neoplasms; Female; Humans; Neoplasm Metastasis; Ovariectomy; Progesterone Congeners; Tamoxifen | 1987 |
Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.
Topics: Aminoglutethimide; Animals; Azasteroids; Breast Neoplasms; Cell Cycle; Cell Line; Danazol; Dexamethasone; Dihydrotestosterone; Estradiol; Flutamide; Humans; Pancreatic Neoplasms; Progesterone; Rats; Receptors, Androgen; Receptors, Estrogen; Tamoxifen | 1986 |
Aromatase inhibitors and the treatment of breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Animals; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Female; Humans; Kinetics; Luteinizing Hormone; Macaca mulatta; Mammary Neoplasms, Experimental; Menopause; Middle Aged; Neoplasms, Hormone-Dependent; Ovary; Rats; Tamoxifen | 1986 |
Beneficial response to pituitary ablation following aminoglutethimide.
Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Female; Humans; Hypophysectomy; Middle Aged; Tamoxifen; Yttrium Radioisotopes | 1986 |
Response of nitrosomethylurea-induced rat mammary tumor to endocrine therapy and comparison with clinical response.
Topics: Aminoglutethimide; Androstenedione; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Danazol; Dihydrotestosterone; Female; Humans; Mammary Neoplasms, Experimental; Menopause; Methylnitrosourea; Ovariectomy; Rats; Tamoxifen | 1986 |
Role of aminoglutethimide in male breast cancer.
Topics: Aminoglutethimide; Breast Neoplasms; Drug Therapy, Combination; Estradiol; Estrone; Humans; Hydrocortisone; Lung Neoplasms; Male; Orchiectomy; Tamoxifen | 1986 |
Metastatic breast cancer: an analysis of prognostic factors in patients treated with aminoglutethimide.
Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Female; Humans; Menopause; Middle Aged; Ovariectomy; Prognosis; Receptors, Estrogen; Tamoxifen | 1987 |
Chemotherapy and hormone therapy of metastatic breast cancer.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Estrogens; Female; Humans; Menopause; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovariectomy; Tamoxifen | 1985 |
Steroid modulation of Mullerian duct regression in the chick embryo.
Topics: Aminoglutethimide; Androstenedione; Animals; Anti-Mullerian Hormone; Chick Embryo; Drug Interactions; Estrogen Antagonists; Estrogens; Female; Glycoproteins; Growth Inhibitors; Male; Mullerian Ducts; Norethindrone; Pyrrolidines; Tamoxifen; Testicular Hormones; Thiophenes | 1985 |
[Various induction therapies in older patients with acute myeloid leukemias].
Topics: Aclarubicin; Adolescent; Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Danazol; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Leukapheresis; Leukemia, Myeloid, Acute; Male; Middle Aged; Naphthacenes; Tamoxifen | 1985 |
[Acute myelomonocytic and monoblastic leukemia with polyradicular symptoms].
Topics: Abducens Nerve; Adult; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebral Hemorrhage; Cerebrospinal Fluid; Cranial Nerve Diseases; Cytarabine; Danazol; Demyelinating Diseases; Facial Paralysis; Female; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Meningism; Methotrexate; Middle Aged; Spinal Nerve Roots; Tamoxifen | 1985 |
Tumour ploidy, response and survival in patients receiving endocrine therapy for advanced breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; DNA, Neoplasm; Female; Flow Cytometry; Histological Techniques; Humans; Hydrocortisone; Middle Aged; Ploidies; Tamoxifen | 1985 |
[AMSA/etoposide (VP 16-213). A phase I/II study in refractory acute myeloid leukemia].
Topics: Aminoacridines; Aminoglutethimide; Amsacrine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Danazol; Drug Evaluation; Drug Resistance; Etoposide; Humans; Leukemia, Myeloid, Acute; Tamoxifen | 1985 |
Management of advanced carcinoma of the breast.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Neoplasm Recurrence, Local; Norethindrone; Norethindrone Acetate; Tamoxifen | 1985 |
Response to aminoglutethimide after failure of tamoxifen therapy in breast cancer.
Topics: Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Estrogen Antagonists; Female; Humans; Middle Aged; Tamoxifen | 1985 |
Comparison of different endocrine therapies in management of bone metastases from breast carcinoma.
Topics: Adrenal Cortex Hormones; Adrenalectomy; Aminoglutethimide; Androgens; Bone Neoplasms; Breast Neoplasms; Estrogens; Female; Humans; Hydrocortisone; Hypophysectomy; Ovariectomy; Progestins; Tamoxifen | 1985 |
Treatment of breast carcinoma with aminoglutethimide.
Topics: Aminoglutethimide; Breast Neoplasms; Cortisone; Dexamethasone; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Receptors, Cell Surface; Tamoxifen | 1984 |
Low-dose aminoglutethimide in treatment of advanced breast cancer.
Topics: Adrenal Glands; Aged; Aminoglutethimide; Breast Neoplasms; Castration; Dehydroepiandrosterone; Drug Evaluation; Estradiol; Estrone; Female; Humans; Middle Aged; Tamoxifen | 1984 |
Use of aminoglutethimide as second-line endocrine therapy in metastatic breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Female; Humans; Middle Aged; Nausea; Neoplasm Recurrence, Local; Palliative Care; Quality of Life; Sleep Stages; Tamoxifen; Time Factors | 1982 |
Cross-over comparison of tamoxifen and aminoglutethimide in advanced breast cancer.
Topics: Aminoglutethimide; Breast Neoplasms; Female; Humans; Hydrocortisone; Menopause; Middle Aged; Neoplasms, Hormone-Dependent; Palliative Care; Tamoxifen; Time Factors | 1982 |
Treatment of advanced breast cancer with aminoglutethimide after therapy with tamoxifen.
Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Dizziness; Edema; Female; Fever; Humans; Middle Aged; Nausea; Neoplasm Metastasis; Palliative Care; Skin Diseases; Sleep Stages; Tamoxifen | 1982 |
Metastatic breast cancer in males. Assessment of endocrine therapy.
Topics: Adrenalectomy; Adult; Aged; Aminoglutethimide; Breast Neoplasms; Castration; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Retrospective Studies; Tamoxifen | 1984 |
Aminoglutethimide in tamoxifen-resistant patients: The Melbourne Experience.
Topics: Adrenal Glands; Adult; Aged; Aminoglutethimide; Breast Neoplasms; Dehydroepiandrosterone; Depression, Chemical; Drug Resistance; Drug Therapy, Combination; Female; Humans; Middle Aged; Tamoxifen; Testosterone; Time Factors | 1982 |
Inhibition of steroid sulfatase activity by danazol.
Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Culture Techniques; Danazol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estrogen Antagonists; Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnadienes; Tamoxifen | 1984 |
The changing role of endocrine therapy in the management of advanced breast cancer.
Topics: Adrenal Glands; Aminoglutethimide; Breast Neoplasms; Bromocriptine; Female; Hormones; Humans; Pituitary Gland; Receptors, Cell Surface; Tamoxifen | 1980 |
Response to aminoglutethimide after tamoxifen therapy in advanced breast cancer.
Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1982 |
Relationship of cyclic AMP binding capacity and estrogen receptor to hormone sensitivity in human breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Castration; Cyclic AMP; Cytosol; Female; Humans; Menopause; Middle Aged; Receptors, Estrogen; Tamoxifen | 1983 |
Combination treatment with tamoxifen and aminoglutethimide in advanced breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Middle Aged; Tamoxifen; Time Factors | 1983 |
Treatment of advanced breast cancer with aminoglutethimide--response after previous tamoxifen treatment.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Fluoxymesterone; Humans; Menopause; Methotrexate; Tamoxifen; Time Factors | 1984 |
[Treatment of metastatic breast cancer with aminoglutethimide after failure of tamoxifen].
Topics: Aminoglutethimide; Breast Neoplasms; Humans; Neoplasm Metastasis; Tamoxifen | 1984 |
Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer.
Topics: Aminoglutethimide; Androgens; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Estrogens; Female; Gonadotropins, Pituitary; Humans; Hydrocortisone; Menopause; Sex Hormone-Binding Globulin; Tamoxifen | 1984 |
Choosing treatment for metastatic breast cancer.
Topics: Aged; Aminoglutethimide; Breast Neoplasms; Female; Hormones; Humans; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1982 |
Prognostic significance of serum prolactin levels in advanced breast cancer.
Topics: Aminoglutethimide; Breast Neoplasms; Danazol; Drug Therapy, Combination; Female; Humans; Menopause; Prognosis; Prolactin; Tamoxifen | 1983 |
Assessment of response of bone metastases to systemic treatment in patients with breast cancer.
Topics: Alkaline Phosphatase; Aminoglutethimide; Antineoplastic Agents; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Calcium; Creatinine; Danazol; Doxorubicin; Drug Therapy, Combination; Female; Humans; Hydroxyproline; Radiography; Tamoxifen; Time Factors; Vincristine | 1983 |
Aminoglutethimide treatment in advanced breast cancer: an efficient therapy as a late endocrine alternative in a sequential therapeutic approach.
Topics: Aminoglutethimide; Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Tamoxifen | 1983 |
Oestrogen receptors and the response of metastatic breast cancer to aminoglutethimide or tamoxifen.
Topics: Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Female; Humans; Receptors, Estrogen; Skin Neoplasms; Tamoxifen; Thoracic Neoplasms | 1981 |
Tamoxifen and aminoglutethimide in the management of patients with advanced endometrial carcinoma not responsive to medroxyprogesterone.
Topics: Adenocarcinoma; Aged; Aminoglutethimide; Drug Resistance; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Middle Aged; Tamoxifen; Uterine Neoplasms | 1981 |
Aminoglutethimide after tamoxifen therapy in advanced breast cancer: M. D. Anderson Hospital experience.
Topics: Aminoglutethimide; Breast Neoplasms; Drug Evaluation; Female; Follow-Up Studies; Humans; Middle Aged; Skin Diseases; Sleep Stages; Tamoxifen; Time Factors | 1982 |
Closing remarks to the conference, Aromatase: New Perspectives for Breast Cancer.
Topics: Aminoglutethimide; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Female; Forecasting; Humans; Oxidoreductases; Tamoxifen | 1982 |
Tamoxifen, aminoglutethimide and danazol: effect of therapy on hormones in post-menopausal patients with breast cancer.
Topics: Aminoglutethimide; Androgens; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Danazol; Drug Therapy, Combination; Estradiol; Female; Gonadotropins, Pituitary; Hormones; Humans; Menopause; Pregnadienes; Tamoxifen | 1982 |
The medical management of breast cancer.
Topics: Adjuvants, Pharmaceutic; Adult; Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Castration; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Hypophysectomy; Melphalan; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Receptors, Estrogen; Tamoxifen | 1982 |
A preliminary assessment of an ultrasonic Doppler method for the study of blood flow in human breast cancer.
Topics: Aminoglutethimide; Breast Neoplasms; Female; Humans; Methods; Regional Blood Flow; Tamoxifen; Ultrasonography | 1982 |
The control of human pancreatic adenocarcinoma xenografts in nude mice by hormone therapy.
Topics: Adenocarcinoma; Aminoglutethimide; Animals; Cyproterone; Hormones; Humans; Hydrocortisone; Male; Mice; Mice, Nude; Middle Aged; Neoplasm Transplantation; Neoplasms, Experimental; Pancreatic Neoplasms; Tamoxifen; Testosterone; Transplantation, Heterologous | 1982 |
Use of aminoglutethimide and hydrocortisone as a "medical adrenalectomy" for treatment of breast carcinoma.
Topics: Adrenal Glands; Adrenalectomy; Aminoglutethimide; Aromatase Inhibitors; Biological Availability; Breast Neoplasms; Castration; Dexamethasone; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Hypophysectomy; Tamoxifen | 1982 |
Less toxic treatment for advanced breast cancer.
Topics: Adrenalectomy; Aminoglutethimide; Breast Neoplasms; Estrogens; Female; Humans; Tamoxifen | 1981 |
Medical adrenalectomy in patients with advanced breast cancer resistant to anti-oestrogen treatment.
Topics: Adrenalectomy; Adult; Aged; Aminoglutethimide; Breast Neoplasms; Castration; Drug Resistance; Estrogen Antagonists; Female; Humans; Menopause; Middle Aged; Tamoxifen | 1981 |
[The adjuvant hormonal therapy of breast cancer].
Topics: Aminoglutethimide; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Diethylstilbestrol; Female; Humans; Lymphatic Metastasis; Neoplasm Staging; Tamoxifen | 1995 |
Lack of estrogenic potential of progesterone- or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells.
Topics: Adenocarcinoma; Alkaline Phosphatase; Aminoglutethimide; Aromatase Inhibitors; Binding, Competitive; Cytosol; Endometrial Neoplasms; Endometrium; Enzyme Induction; Enzyme Inhibitors; Estradiol Congeners; Estrogens; Ethinyl Estradiol; Female; Humans; Nandrolone; Norpregnanes; Norprogesterones; Pregnanes; Progesterone; Progestins; Receptors, Estrogen; Tamoxifen; Testosterone; Tumor Cells, Cultured | 1995 |
Megestrol acetate in advanced breast carcinoma.
Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Cross-Over Studies; Female; Humans; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Postmenopause; Prospective Studies; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome | 1994 |
[Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy].
Topics: Adult; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Danazol; Drug Evaluation; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mitoxantrone; Prognosis; Remission Induction; Tamoxifen; Time Factors; Tretinoin | 1994 |
Reduced occurrence of mdr-1 amplification in stage-IV breast-cancer patients treated with tamoxifen compared with other endocrine treatments.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biopsy, Needle; Breast Neoplasms; DNA, Neoplasm; Gene Amplification; Humans; Membrane Glycoproteins; Middle Aged; Progesterone; Tamoxifen; Testosterone | 1993 |
Trisomy 21 as the sole clonal aberration in a patient with acute myelomonocytic leukemia with abnormal bone marrow eosinophils and extramedullary involvement.
Topics: Adult; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Danazol; Down Syndrome; Eosinophils; Humans; Leukemia, Myelomonocytic, Acute; Male; Tamoxifen | 1994 |
Factors influencing aromatase activity in the breast.
Topics: Adipose Tissue; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Aromatase; Breast; Breast Diseases; Breast Neoplasms; Bucladesine; Cells, Cultured; Culture Media, Conditioned; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Hydrocortisone; Kinetics; Prednisone; Tamoxifen; Vincristine | 1993 |
Appearance of amplified thymidylate synthase or dihydrofolate reductase genes in stage-IV breast-cancer patients receiving endocrine treatment.
Topics: Aminoglutethimide; Base Sequence; Biopsy, Needle; Breast Neoplasms; DNA, Neoplasm; Drug Resistance; Female; Gene Amplification; Genes; Humans; Molecular Sequence Data; Oligodeoxyribonucleotides; Polymerase Chain Reaction; Progesterone; Tamoxifen; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase; Time Factors | 1993 |
C-erb-b2/int-2 amplification appears faster in breast-cancer patients receiving second-line endocrine treatment.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents, Hormonal; Biopsy, Needle; Breast Neoplasms; Female; Fibroblast Growth Factor 3; Fibroblast Growth Factors; Gene Amplification; Genes, erbB-2; Humans; Middle Aged; Polymerase Chain Reaction; Progesterone; Proto-Oncogene Proteins; Tamoxifen; Testosterone | 1996 |
Predictors of response to second-line endocrine therapy for breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Gonanes; Goserelin; Humans; Megestrol Acetate; Middle Aged; Nitriles; Ovariectomy; Predictive Value of Tests; Remission Induction; Tamoxifen; Triazoles | 1997 |
Inhibition of 11 beta-hydroxysteroid dehydrogenase activity enhances the antiproliferative effect of glucocorticosteroids on MCF-7 and ZR-75-1 breast cancer cells.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Administration, Topical; Aminoglutethimide; Analysis of Variance; Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cell Division; Cells, Cultured; Dexamethasone; Female; Glucocorticoids; Glycyrrhetinic Acid; Humans; Hydroxysteroid Dehydrogenases; Prednisolone; Tamoxifen; Tumor Cells, Cultured | 1997 |
Regulation of low density lipoprotein receptor mRNA levels by estradiol 17beta and chorionic gonadotropin in human placenta.
Topics: Aminoglutethimide; Androstatrienes; Aromatase Inhibitors; Blotting, Northern; Cholesterol; Chorionic Gonadotropin; Cycloheximide; Estradiol; Estrogen Antagonists; Female; Gene Expression Regulation, Developmental; Humans; In Vitro Techniques; Placenta; Placentation; Pregnancy; Pregnancy Trimester, First; Progesterone; Receptors, LDL; RNA, Messenger; Tamoxifen | 1998 |
Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia.
Topics: Adult; Aged; alpha 1-Antitrypsin; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blast Crisis; Bleomycin; Bone Marrow; Cyclophosphamide; Dacarbazine; Danazol; Disease-Free Survival; Doxorubicin; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nimustine; Peptide Fragments; Prednisone; Probability; Procarbazine; Prognosis; Proteinuria; Recurrence; Remission Induction; Reproducibility of Results; Tamoxifen; Time Factors; Vincristine | 1995 |
[Aromatase inhibitors].
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Enzyme Inhibitors; Tamoxifen | 2000 |
Induction of atypical ductal hyperplasia in mouse mammary gland organ culture.
Topics: Aminoglutethimide; Animals; Aromatase Inhibitors; Enzyme Inhibitors; Estradiol; Estrogen Receptor Modulators; Female; Hormones; Hyperplasia; Insulin; Mammary Glands, Animal; Mice; Organ Culture Techniques; Progesterone; Prolactin; Tamoxifen; Time Factors; Toremifene | 2001 |
Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3;3) (q21;q26) positive AML.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Chromosome Inversion; Chromosomes, Human, Pair 3; Cohort Studies; Cytarabine; Danazol; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Karyotyping; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Mitoxantrone; Prognosis; Survival Analysis; Tamoxifen; Translocation, Genetic | 2007 |
The effects of aromatase inhibitors and selective estrogen receptor modulators on eye development in the zebrafish (Danio rerio).
Topics: Aminoglutethimide; Androstenedione; Animals; Aromatase Inhibitors; Clomiphene; Embryo, Nonmammalian; Embryonic Development; Estrogens; Eye; Retina; Selective Estrogen Receptor Modulators; Tamoxifen; Zebrafish | 2007 |
Extended adjuvant therapy for breast cancer--how much is enough?
Topics: Aminoglutethimide; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Austria; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome; Triazoles | 2007 |